首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
【2h】

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.

机译:Teicoplanin与nafcillin和万古霉素治疗对甲氧西林敏感或耐药的金黄色葡萄球菌引起的实验性心内膜炎。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In rabbits with experimentally induced endocarditis, the efficacy of teicoplanin compared favorably both with that of nafcillin for infection by a methicillin-susceptible strain of Staphylococcus aureus and with that of vancomycin for infection by a methicillin-resistant strain of S. aureus. In a 4-day treatment regimen, teicoplanin was as effective as either nafcillin or vancomycin in eliminating organisms from aortic valve vegetations in the respective infection. In a 10-day regimen for methicillin-resistant S. aureus endocarditis, both teicoplanin and vancomycin sterilized the vegetations of some rabbits, but the relapse rate was high for both. These results justify further investigation into the role of teicoplanin for the treatment of serious infections caused by S. aureus.
机译:在患有实验性心内膜炎的兔子中,替考拉宁的疗效与纳夫西林对耐甲氧西林敏感的金黄色葡萄球菌菌株的感染以及万古霉素对耐甲氧西林的金黄色葡萄球菌感染的疗效均良好。在为期4天的治疗方案中,替考拉宁与纳夫西林或万古霉素在清除相应感染的主动脉瓣植物中的生物上一样有效。在耐甲氧西林的金黄色葡萄球菌性心内膜炎的10天疗程中,替考拉宁和万古霉素均对部分兔子的植被进行了灭菌,但两者的复发率均很高。这些结果证明进一步研究替考拉宁在治疗金黄色葡萄球菌引起的严重感染中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号